Navigate Fool.com
Will REGN beat
the market?
Community Rating: 2 Stars: Unattractive

303.09 -1.35 (-0.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $303.46
Previous Close $304.44
Daily Range $300.22 - $305.01
52-Week Range $227.64 - $352.49
Market Cap $30.6B
P/E Ratio 87.23
Dividend (Yield) $0.00 (0.0%)
Volume 369,087
Average Daily Volume 971,330
Current FY EPS $9.29

How do you think REGN
will perform against the market?

Top REGN Bull/Bear Pitches


TMFTycoon (< 20)
Submitted March 20, 2014

Things are looking good for Eylea, one of Regeneron's drugs, and it is scheduled for further regulatory decisions and Phase III testing later this year.

0 Replies Reply Report this Post

davidm9999 (0)
Submitted November 11, 2013

Given its precipitous rise, REGN is due for a correction. Its PE has been gamed using a $470M tax credit to bring it from 53 to 40. Further, the company's blockbuster product Eylea has generated subst … More

4 Replies Reply Report this Post

News & Commentary Rss Feed

5 Novartis Drugs You Need To Know About

Biogen (BIIB) and Regeneron (REGN) pose threats to Novartis' (NVS) sales as Diovan competitors launch.

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Sector Update: Health Care Shares Mixed Pre-Market

Sector Update: Health Care

Notable Two Hundred Day Moving Average Cross - REGN

Regeneron, Sanofi Drug Holds Up in Eczema Study

Read below for more on this exciting story.

Sanofi buys big chunk of Regeneron shares

Nasdaq 100 Movers: GRMN, ORLY

Is Opthotech Your Next Multibagger Stock?

Opthotech is working on a treatment for wet AMD that could have sales potential equal to that of Novartis' Lucentis or Regeneron's (REGN) Eylea.

Nasdaq 100 Movers: BIDU, STX

See More REGN News...





Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks